Table 2.
Analytes (pg/mL) |
Normocapnia (5% CO2) | Hypercapnia (20% CO2) | Fold Diff. | ||||
---|---|---|---|---|---|---|---|
Mean | Stdev | SEM | Mean | Stdev | SEM | ||
IL-1α | 8.9 | 18.3 | 10.6 | 15.4 | 1.2 | 0.7 | 1.7 |
IL-6 | 4654.9 | 157.7 | 91.0 | 184.1 | 0.1 | 0.1 | 0.0 |
IL-8 | 328.8 | 28.9 | 16.7 | 163.8 | 0.4 | 0.2 | 0.5 |
IL-13 | 1.6 | 0.1 | 0.1 | 1.3 | 0.1 | 0.0 | 0.8 |
IFNβ | 17.3 | 35.1 | 20.3 | 43.6 | 2.2 | 1.3 | 2.5 |
TNFα | 2.1 | 0.1 | 0.0 | 0.5 | 2.4 | 1.4 | 0.2 |
HGF | 9573.9 | 4395.3 | 2537.6 | 5961.2 | 1.0 | 0.6 | 0.6 |
VEGF | 422.0 | 67.7 | 39.1 | 267.6 | 0.6 | 0.4 | 0.6 |
LIF | 448.5 | 191.6 | 110.6 | 518.6 | 0.3 | 0.2 | 1.2 |
Perforins | 5.9 | 2.4 | 1.4 | 8.4 | 0.8 | 0.4 | 1.4 |
n = 3; Wilcoxon matched-pairs signed rank test; no statistical significance was observed; concentration in pg/mL normalised to total protein concentration for each sample.